▲ Peaking
Health
Seattle breakthrough offers Spokane boy relief from rare hunger condition
A new FDA-approved therapy, setmelanotide, is providing relief for patients with hypothalamic obesity caused by brain injury.
Coverage by NR Times as tracked by Newsylist.
A new FDA-approved therapy, setmelanotide, is providing relief for patients with hypothalamic obesity caused by brain injury.